AstraZeneca PLC
26 March 2008
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DTR 3.1.4R
We hereby inform you that the interest of Anthony Zook, a person discharging
managerial responsibility, in the shares of AstraZeneca PLC has changed as
detailed below. Mr Zook has interests in the American Depositary Shares (ADSs)
of AstraZeneca PLC. One ADS equals one Ordinary Share.
On 24 March 2008, Mr Zook became unconditionally entitled to a final award of
7,717 ADSs on the partial vesting of an original target award of 8,039 ADSs,
which were awarded to him in March 2005 under the terms of the AstraZeneca US
Executive Performance Share Plan. Mr Zook has ceased to have an interest in the
322 ADSs of the original target award that did not vest. After certain
mandatory tax deductions, Mr Zook has received 5,217 ADSs into a personal
brokerage account.
The closing price of AstraZeneca ADSs on 20 March 2008 was US$37.63.
G H R Musker
Company Secretary
26 March 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.